Customer Logins

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.

Customer Logins

PharmOnline International (POLI)

Set the optimal pharmaceutical product price and identify pricing opportunities across the product life cycle

Pressed to make informed global pharmaceutical pricing decisions? Need to negotiate or defend the price and reimbursement of your product, or explore pricing strategies and opportunities?

POLI is the leading global pharmaceutical pricing database trusted by pricing executives, payors and associations around the world. This highly intuitive tool and data browser allows you to make one-click comparisons of drug prices, costs, launch timelines and reimbursement across 80 countries. With advanced business reporting tools and analytics, POLI provides unparalleled insights into key pricing drivers, impact of generics, biosimilars and parallel trade, launch sequence analysis, pricing opportunities, and defensive pricing strategies.

POLI can be used to:

  • Analyze and monitor the competitive pricing environment
  • Determine and optimize initial pricing and launching sequence
  • Determine optimum post-Loss of Exclusivity (LoE) strategy and pricing opportunities
  • Support dossier submissions and pricing negotiations
  • Assess business impact of International Reference Pricing (IRP) and other P&R events
  • View aggregate indicators and analytics, broken down by therapeutic class or product classification
  • Compare and chart pharmaceutical prices and costs at current prices or over time
  • Improve/compare market access and time-to-market strategies
  • Create strategic pharmaceutical pricing, launch sequence and IRP models

What’s Included

Data

Easily make cross-country P&R comparisons across more than 80 developed and emerging markets. Our data uses a consistent methodology across each market.

  • Ex-factory, wholesale, pharmacy and retail prices
  • Therapeutic areas
  • Company portfolio insight
  • Historical pharma pricing data
  • Time-to-market and reimbursement rate data
  • Indication-specific cost data based on detailed assumptions on induction/maintenance dosing, average duration of use, average weight/body surface area and more
  • Indication-specific HTA/reimbursement data, including the clinical data used to support dossier submissions and tracking clinical trials of future therapies


Click to enlarge

Analysis
  • Aggregate analytics on time-to-launch, launch sequence, reimbursement levels, average price cuts, and impact of generics
  • Aggregate analytics on therapeutic classes, orphan disease products, breakthrough therapies, parallel traded products, generics, branded generics, biosimilars, vaccines, medical devices and more
  • Monthly editorial bulletins from our pricing experts on new price trends, impact of new products, and analysis of ongoing strategic themes
Tools
  • Advanced charting functionality of price histories and current price comparisons
  • Bespoke saved searches of your selected products or analytics to build reports
  • Email notifications instantly informing you of price changes
  • Daily currency conversion
  • Direct links to sources
  • Data browser to create bespoke analytics
  • Expert Access: Timely response and assistance from our team of pricing and reimbursement country analysts and health economic experts
Delivery Options

Connect®
Maximize your subscription content with IHS Markit Connect – our online customer platform. Connect is a one-stop solution for data searching and discovery, charting, downloading and saving for future use.

  • Filter by price change time periods
  • Full “and, or, not” Boolean logic available
  • Column customization and sorting
  • Save searches and view preferences
  • Download price history in time series
  • Month-on-month data makes trend analysis much easier
  • Convert local currency prices to 80 different currencies, with daily rates
  • Price change email alerts list which geographies and presentations have seen price changes, and in which direction
  • Indicators from raw prices for price trends, time to market and reimbursement list size (for full 80-country subscribers)

REST API
Our API delivers data continuously and reliably directly into your workflow.

  • Representational State Transfer Application Programming (REST) API makes data available via URL addresses (or ‘endpoints’)
  • Provides a foundation on which to build databases, charts, websites, visualizations and CSV files, plus facilities to query and lookup specific data
  • Offers the simplest approach to application integration:
    • Access to the API is instantaneous
    • Provides an interactive web environment for developers to explore API features and review technical documentation
    • Developers can test the API calls interactively in a browser
  • 24/7 monitoring and support is provided
  • Scales horizontally for both datasets and clients, ensuring it can meet present and future demand
  • Built for consistent speed, with carefully selected technologies to ensure the best possible performance

IDDS
IDDS offers tailored data feeds featuring continuous updating and seamless delivery.

  • Internet Data Delivery System (IDDS) delivers fixed data updates in CSV or XML format to the IHS Markit web servers in real time
  • Metadata includes economic concept, geography, source and frequency
  • Updates pull in data changes only, optimizing load speed
  • Data updates can be scheduled

Solve Your Business Challenge

Challenge Solution
I need to track pharmaceutical pricing across countries and develop pharmaceutical pricing and launch sequencing strategies. Make one-click price comparisons across 80 developed and emerging markets.
I need to understand competitor pricing in different countries. Get continually updated data on pricing, market entrants, approvals and P&R listings.
I need to forecast future price swings and pricing opportunities Access historical price data to follow disease area trends, compare product/therapeutic area P&R status, and time-to-market access.
I need to understand comparative time-to-market and reimbursement trends. Access average to approval, reimbursement time and time to launch for individual drugs, therapeutic areas, or countries.

Experts

Gustav Ando

Executive Director, Life Sciences, IHS Markit

Milena Izmirlieva

Director, Life Sciences Research, IHS Markit

Follow IHS Markit Life Sciences on Twitter

Follow Life Sciences Research and Analysis

You may be interested in

Industries

Explore

RELATED INDUSTRIES & TOPICS
Filter Sort